Ali Tehrani - 15 Jul 2021 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
15 Jul 2021
Transactions value $
-$1,427,794
Form type
4
Filing time
16 Jul 2021, 21:30:18 UTC
Previous filing
13 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Shares Options Exercise $16.2K +3.8K +1.46% $4.27* 264K 15 Jul 2021 Direct F1, F2
transaction ZYME Common Shares Sale -$137K -3.8K -1.44% $36.00* 260K 15 Jul 2021 Direct F1, F3
transaction ZYME Common Shares Options Exercise $176K +41.2K +15.82% $4.26* 302K 16 Jul 2021 Direct F1, F4
transaction ZYME Common Shares Sale -$1.48M -41.2K -13.66% $36.00* 260K 16 Jul 2021 Direct F1, F3
holding ZYME Common Shares 55.5K 15 Jul 2021 Held by spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Options Exercise $0 -3.8K -8.45% $0.00 41.2K 15 Jul 2021 Common Shares 3.8K $4.27 Direct F1, F2, F5
transaction ZYME Stock Option (Right to Buy) Options Exercise $0 -41.2K -100% $0.00* 0 16 Jul 2021 Common Shares 41.2K $4.26 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a 10b5-1 plan entered into May 13, 2021.
F2 The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.2713 using the Bank of Canada exchange rate for July 15, 2021 (CAD1.00 = $0.7954).
F3 All shares were sold at $36.00 per share.
F4 The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.2643 using the Bank of Canada exchange rate for July 16, 2021 (CAD1.00 = $0.7941).
F5 Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2012 and (ii) remainder of underlying shares in 36 equal monthly installments on the last day of month following first anniversary of grant date.